From 11th to 14th November, 2024, Singclean made a brilliant appearance at the world's largest medical industry event - MEDICA in Germany, with its latest medical aesthetic product Singderm®Dual hydroxyapatite composite filler for injection. Singderm®Dual won wide attention and high praise from the participants with its excellent performance and innovative technology.
Singderm attracted a lot of attention on the site, attracting many visitors to stop by. ‘Singderm Dual’, i.e. hydroxyapatite composite filler for injection, is difficult to develop and requires high safety. It combines two active ingredients - hyaluronic acid (HA) and hydroxyapatite (CaHA) - in the same syringe, giving full play to the synergistic effect of hyaluronic acid and hydroxyapatite. The synergistic effect of sodium hyaluronate and hydroxyapatite.
Double anti-aging effect in one injection, 20mg/mL high viscoelastic cross-linked hyaluronic acid HA, instantly plumping and lifting the facial contour. 55.7% hydroxyapatite CaHA microspheres stimulate collagen production in the underlying layers of the skin, increasing skin thickness, firming the face and restoring skin elasticity. 0.3% Lidocaine improves injection comfort, and the product can be completely degraded and absorbed, with the effect lasting up to two years.
Singderm® Dual meets the needs of the high-end medical aesthetic market for safety, durability and naturalness of injectable materials as consumers' demand for aesthetic results increases, and provides more natural and longer-lasting aesthetic results to satisfy the needs of more consumers and the high-end market who are looking for high-quality treatment results.
Singderm® Dual CaHA Filler, with its original product characteristics, excellent performance in adhesion and elasticity, and more excellent and stable filling and shaping effects will be leading the world in a new trend of age-reversal and open up a new era of facial rejuvenation!
In addition to Singderm® Dual CaHA Filler, brand director, Abby Xu proudly displayed other medical aesthetic regenerative material series products newly developed by : Singderm® PLLA Filler has already been in the clinical trials and has been highly praised by doctors and subjects.
SKformula PDRN Skin Booster, has received a large number of enquiries from overseas customers.
In the future, Singclean will increase its investment in the European market and accelerate the progress of new product registration, so as to bring more comprehensive and customised anti-aging solutions to European and global beauty seekers.